Good, and pretty obvious metrics, at least for those who would pay attention. I had thought of the first two. We could, in fact, have benefited from all three for COVID, especially after we decided to essentially stop relatively widespread, if still sparse testing. Thanks for the analyses.
Good, and pretty obvious metrics, at least for those who would pay attention. I had thought of the first two. We could, in fact, have benefited from all three for COVID, especially after we decided to essentially stop relatively widespread, if still sparse testing. Thanks for the analyses.